<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04774731</url>
  </required_header>
  <id_info>
    <org_study_id>WBV-HD</org_study_id>
    <nct_id>NCT04774731</nct_id>
  </id_info>
  <brief_title>Effect of Whole Body Vibration on Walking Performance in Elderly Hemodialysis Patients</brief_title>
  <official_title>A Randomized Controlled Trial to Evaluate the Efficacy of Whole Body Vibration on Walking Performance in Elderly Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Osaka University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Osaka University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of whole body vibration for 12 weeks on&#xD;
      walking performance in elderly hemodialysis patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, prospective, randomized controlled trial. Eligible subjects will be&#xD;
      randomized in a 1:1 ratio to a whole-body vibration (WBV) group or controlled group. Patients&#xD;
      in a WBV group will receive WBV training three times a week before initiation of dialysis&#xD;
      sessions for 12 weeks. The primary outcome of the study will be the change in walking&#xD;
      performance assessed by the timed up and go test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the timed up and go test</measure>
    <time_frame>12 weeks after starting intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the one-leg standing test</measure>
    <time_frame>12 weeks after starting intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the 30-second chair-stand test</measure>
    <time_frame>12 weeks after starting intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hemodialysis</condition>
  <arm_group>
    <arm_group_label>Whole Body Vibration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole Body Vibration</intervention_name>
    <description>Receiving WBV training three times a week before initiation of dialysis sessions for 12 weeks. Subjects stand on a platform of WBV for 3 minutes in every training session.</description>
    <arm_group_label>Whole Body Vibration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Undergoing maintenance hemodialysis three times a week .&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having difficulty in walking by oneself.&#xD;
&#xD;
          -  Having difficulty in receiving whole body vibration training because of cognitive&#xD;
             impairment.&#xD;
&#xD;
          -  History of fracture of lower limb within 1 year.&#xD;
&#xD;
          -  History of total hip arthroplasty.&#xD;
&#xD;
          -  Unsuitable for participant in the trial by an attending physician.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yusuke Sakaguchi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Nephrology, Osaka University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yusuke Sakaguchi, MD, PhD</last_name>
    <phone>+81-6-6879-3857</phone>
    <email>sakaguchi@kid.med.osaka-u.ac.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Osaka University Hospital</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <zip>5650871</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yusuke Sakaguchi, MD, PhD</last_name>
      <phone>+81-6-6879-3857</phone>
      <email>sakaguchi@kid.med.osaka-u.ac.jp</email>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 24, 2021</study_first_submitted>
  <study_first_submitted_qc>February 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Osaka University</investigator_affiliation>
    <investigator_full_name>Yusuke Sakaguchi</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <keyword>whole body vibration</keyword>
  <keyword>hemodialysis</keyword>
  <keyword>gait function</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

